Who owns Oramed Pharm?
- Ticker: ORMP
- CUSIP Number: 68403P203
Tip: Access positions for across all investors
Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oramed Pharm stock
Who bought or sold Oramed Pharm this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 3.2M | $9.0M | 0% | Dec 2025 |
|
| Aquamarine Financial | 2.0M | $5.6M | 0% | Dec 2025 |
|
| SB Capital Management | 1.9M | $5.4M | 100% | Dec 2025 |
|
| Murchinson | 1.3M | $3.8M | -23% | Dec 2025 |
|
| Boothbay Fund Management | 612k | $1.7M | -28% | Dec 2025 |
|
| Marshall Wace | 259k | $738k | 100% | Dec 2025 |
|
| Rathbones Brothers | 233k | $664k | 0% | Dec 2025 |
|
| Dimensional Fund Advisors | 151k | $429k | 2% | Dec 2025 |
|
| Renaissance Technologies | 148k | $420k | -1% | Dec 2025 |
|
| Wells Fargo & Company | 131k | $372k | 0% | Dec 2025 |
|
| Citadel Advisors | 112k | $295k | 1% | Sep 2025 |
|
| BlackRock | 90k | $257k | -18% | Dec 2025 |
|
| Jane Street | 78k | $223k | 31% | Dec 2025 |
|
| Squarepoint Ops | 58k | $166k | 95% | Dec 2025 |
|
| Hrt Financial | 46k | $131k | 100% | Dec 2025 |
|
| Connor, Clark & Lunn Investment Management | 44k | $125k | 55% | Dec 2025 |
|
| Rbf Capital | 43k | $113k | 0% | Sep 2025 |
|
| Quadrature Capital | 42k | $119k | 100% | Dec 2025 |
|
| XTX Topco | 38k | $109k | 60% | Dec 2025 |
|
| Susquehanna International | 26k | $74k | -29% | Dec 2025 |
|
| Point72 Asset Management | 25k | $73k | 100% | Dec 2025 |
|
| Geode Capital Management | 24k | $69k | 0% | Dec 2025 |
|
| Two Sigma Securities | 23k | $66k | 100% | Dec 2025 |
|
| Pnc Financial Services | 21k | $60k | -9% | Dec 2025 |
|
| American Century Companies | 20k | $56k | 0% | Dec 2025 |
|
| Wealth Enhancement Advisory Services | 18k | $56k | -3% | Dec 2025 |
|
| Sage Capital Management | 17k | $48k | 0% | Dec 2025 |
|
| LPL Financial | 13k | $38k | -3% | Dec 2025 |
|
| Close Asset Management | 12k | $33k | 0% | Dec 2025 |
|
| Altshuler Shaham | 11k | $32k | 0% | Dec 2025 |
|
| Mariner Wealth Advisors | 11k | $31k | 0% | Dec 2025 |
|
| Glass Jacobson Investment Advisors | 11k | $30k | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 9.3k | $26k | 5% | Dec 2025 |
|
| Barclays | 6.9k | $20k | -48% | Dec 2025 |
|
| Advisor Group Holdings | 4.3k | $12k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 3.5k | $9.0k | -93% | Sep 2025 |
|
| N.E.W. Advisory Services | 3.2k | $9.1k | 100% | Dec 2025 |
|
| Huntington National Bank | 3.0k | $8.6k | 0% | Dec 2025 |
|
| UBS Group | 2.6k | $7.3k | 621% | Dec 2025 |
|
| MAI Wealth Advisors | 2.1k | $5.9k | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 1.7k | $4.9k | 8% | Dec 2025 |
|
| SBI Securities | 1.6k | $4.2k | -3% | Sep 2025 |
|
| Simplex Trading | 1.1k | $3.3k | 100% | Dec 2025 |
|
| Caitlin John | 1.0k | $2.9k | 100% | Dec 2025 |
|
| McIlrath & Eck | 1.0k | $2.9k | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 714.00 | $1.7k | 43% | Sep 2025 |
|
| Tower Research Capital | 693.00 | $2.0k | 100% | Dec 2025 |
|
| IFP Advisors | 500.00 | $1.4k | 0% | Dec 2025 |
|
| FMR | 500.00 | $1.3k | 100% | Sep 2025 |
|
| Golden State Wealth Management | 303.00 | $864.004500 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 170.00 | $449.089000 | 100% | Sep 2025 |
|
Who sold out of Oramed Pharm?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Raymond James Financial | Jun 2025 | 3.6k | $8.0k |
| Newbridge Financial Services Group | Sep 2025 | 1.0k | $2.6k |
| Hanson McClain Advisors | Sep 2025 | 300.00 | $792.000000 |
| Hopwood Financial Services | Sep 2025 | 200.00 | $528.000000 |